Repligen (RGEN) Net Equity Issued and Repurchased (2019 - 2023)
Repligen's (RGEN) quarterly Net Equity Issued and Repurchased came in at -$10000.0 in Q3 2023, down 100.01% on a QoQ basis from $131.1 million in Q3 2019.
Repligen (RGEN) Net Equity Issued and Repurchased (2019 - 2023) Analysis & Trends
Repligen (RGEN) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$10000.0 in Q3 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$10000.0 in Q3 2023; TTM through Sep 2023 was -$10000.0, a 100.01% decrease from a year earlier, with the FY2020 full-year figure at $297.8 million, down 7.15% from the prior year.
- Net Equity Issued and Repurchased for Q3 2023 stood at -$10000.0, down from $131.1 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for RGEN reached as high as $131.1 million in Q3 2019 and fell as low as -$10000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7.43 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.72 Mn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2019 | 131.09 Mn |
| Sep 30, 2019 | 131.09 Mn |